OpenAI has restructured into a nonprofit foundation and a separate for-profit subsidiary (public benefit corporation). OpenAI plans to invest $25 billion in health research and biodefense, particularly through its support of the startup Valthos. As the company advances toward artificial general intelligence, there are growing concerns about the risks of AI misuse in biological contexts, underscoring the need for responsible development and safeguards to mitigate these dangers.
This is an ainewsarticles.com news flash; the original news article can be found here: Read the Full Article…
